» Articles » PMID: 2861375

Ciprofloxacin-resistant Pseudomonas

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1985 Jun 22
PMID 2861375
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection.

Marchbanks C, McKiel J, GILBERT D, Robillard N, Painter B, Zinner S Antimicrob Agents Chemother. 1993; 37(9):1756-63.

PMID: 8239581 PMC: 188066. DOI: 10.1128/AAC.37.9.1756.


Bacterial resistance to fluoroquinolones: lessons to be learned.

Ball P Infection. 1994; 22 Suppl 2:S140-7.

PMID: 7927833 DOI: 10.1007/BF01793579.


Cloning of multidrug resistance gene pqrA from Proteus vulgaris.

Ishida H, Fuziwara H, Kaibori Y, Horiuchi T, Sato K, Osada Y Antimicrob Agents Chemother. 1995; 39(2):453-7.

PMID: 7726514 PMC: 162559. DOI: 10.1128/AAC.39.2.453.


Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

Jensen T, Pedersen S, Hoiby N, Koch C Eur J Clin Microbiol. 1987; 6(6):618-22.

PMID: 3326741 DOI: 10.1007/BF02013055.


Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Monk J, Price A, Benfield P, Todd P, Ward A Drugs. 1988; 35(4):373-447.

PMID: 3292209 DOI: 10.2165/00003495-198835040-00003.